Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | CPA1 | P15085 | 3/20 | 0.48 |
| ▸ | CPA3 | P15088 | 3/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475786 | 1.00 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL20494781 | 0.85 | SLC7A5 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL27878043 | 0.85 | ALPI (0.53) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL25212796 | 0.85 | CYP1A2 (0.52) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL27878042 | 0.85 | ALPI (0.53) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL25212797 | 0.85 | CYP1A2 (0.52) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL29462781 | 0.83 | SOAT1 (0.41) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL23270969 | 0.82 | CYP1A2 (0.48) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL6006043 | 0.82 | CYP1A2 (0.48) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL23270961 | 0.82 | CYP1A2 (0.48) | CYP1A2ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119715853-A | Semi-quantitative assessment method for substitution degree of non-protein amino acid | 遵义医科大学 | 2025-03-28 | — | — | CN | claimed |
| EP-3347369-B1 | NOVEL COMPOUNDS WITH DUAL ACTIVITY | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2024-04-17 | — | — | EP | claimed |
| US-8883721-B2 | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof | MCGILL UNIVERSITY (CA) | 2014-11-11 | — | — | US | claimed |
| WO-2013142229-A1 | DESIGNING NOVEL PEPTIDES FOR INDUCING FIBRONECTIN MATRIX ASSEMBLY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-09-26 | — | — | WO | claimed |
| US-20120135918-A1 | METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF | MCGILL UNIVERSITY (CA) | 2012-05-31 | — | — | US | claimed |
| WO-2011126882-A2 | THERAPEUTIC PEPTIDES AND THEIR DERIVATIVES AND THERAPEUTIC USES THEREOF | AMERICAN TYPE CULTURE COLLECTION (US) | 2011-10-13 | — | — | WO | claimed |
| WO-2010132580-A2 | METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2010-11-18 | — | — | WO | claimed |
| US-20060148714-A1 | Therapeutic peptide-based constructs | LITTLE ROGER G II | 2006-07-06 | — | — | US | claimed |
| US-6964948-B2 | Therapeutic peptide-based constructs derived from Domain II of bactericidal/permeability-increasing protein | XOMA TECHNOLOGY LTD. (BM) | 2005-11-15 | — | — | US | claimed |
| US-6906037-B2 | Therapeutic peptide-based constructs | XOMA TECHNOLOGY LTD. (BM) | 2005-06-14 | — | — | US | claimed |
| US-20040048793-A1 | Therapeutic peptide-based constructs | LITTLE ROGER G (US) | 2004-03-11 | — | — | US | claimed |
| US-20030144195-A1 | Therapeutic peptide-based constructs | LITTLE ROGER G (US) | 2003-07-31 | — | — | US | claimed |
| US-6515104-B1 | 8-15 amino acid moieties having heparin neutralization and binding and inhibiting endothelial cell proliferation and/or angiogenesis; diagnotic applications | XOMA TECHNOLOGY LTD. (BM) | 2003-02-04 | — | — | US | claimed |
| US-6423825-B1 | OCTA-, NONA-, DECA- OR POLYPEPTIDE; HEPARIN BINDING AND NEUTRALIZATION; ANTIPROLIFERATIVE AGENTS OF ENDOTHELIAL CELLS; ANGIOGENESIS INHIBITORS | XOMA TECHNOLOGY LTD. (BM) | 2002-07-23 | — | — | US | claimed |
| EP-1196440-A2 | THERAPEUTIC PEPTIDES DERIVED FROM SUBSEQUENCES OF BPI | XOMA Technology Ltd. (US) | 2002-04-17 | — | — | EP | claimed |
| US-6355616-B1 | FUNGICIDE OLIGOPEOTIDES | XOMA (US) TECHNOLOGY LTD. | 2002-03-12 | — | — | US | claimed |
| WO-2001000671-A1 | DERIVATIVE COMPOUNDS | XOMA TECHNOLOGY LTD. (US) | 2001-01-04 | — | — | WO | claimed |
| WO-2001000655-A2 | THERAPEUTIC PEPTIDES DERIVED FROM SUBSEQUENCES OF BPI | XOMA TECHNOLOGY LTD. (US) | 2001-01-04 | — | — | WO | claimed |
| EP-4748438-A2 | ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES | Cedars-Sinai Medical Center (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2000011022-A1 | ANTI-CANCER COMPOUNDS AND METHODS RELATED THERETO | STEWART JOHN M (US) | 2000-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135918-A1 | METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF | GHSR, GIPR, GHRHR | CYP1A2 3570/4885ALPI 2152/4885PKM 4294/4885 |
| US-20060148714-A1 | Therapeutic peptide-based constructs | SPPL2B, LNPEP, VIP | CYP1A2 4885/4885ALPI 1779/4885PKM 3769/4885 |
| US-20030144195-A1 | Therapeutic peptide-based constructs | LNPEP, SPPL2B, ENPEP | CYP1A2 4883/4885ALPI 1454/4885PKM 3804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.